The synthesis of complex pharmaceutical intermediates is a cornerstone of modern drug development. NS-304 (CAS 475086-01-2), known more broadly as Selexipag, is a prime example of such a critical molecule, integral to research in cardiovascular and pulmonary medicine. NINGBO INNO PHARMCHEM CO.,LTD., a prominent manufacturer in China, specializes in providing this high-value chemical intermediate.

NS-304 is chemically identified as 2-[4-[(5,6-diphenylpyrazin-2-yl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide. Its synthesis involves intricate chemical steps to ensure the precise structure and high purity required for its function as a prodrug for MRE-269. As an IP receptor agonist, NS-304's biological activity is directly linked to its molecular integrity. This underscores the importance of sourcing from a reputable NS-304 supplier capable of delivering consistently pure material.

The applications of NS-304 extend across various stages of drug development. It is used in early-stage research to probe the IP receptor's role in cellular signaling and in preclinical studies to evaluate therapeutic efficacy in disease models, such as pulmonary arterial hypertension. For companies looking to buy NS-304, understanding its role as a pharmaceutical intermediate is key. It's not just a chemical compound; it's a building block for innovative therapies.

NINGBO INNO PHARMCHEM CO.,LTD. prides itself on its advanced chemical synthesis capabilities and stringent quality control measures. We offer our clients not only superior quality NS-304 but also competitive NS-304 price points, making essential research materials accessible. Our commitment to being a reliable pharmaceutical intermediate supplier means we are dedicated to supporting your R&D efforts from discovery through to commercialization. Partner with us to secure your supply of this vital compound.